Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Modulation of immune response via monounsaturated fatty acids does not refer to a single canonical molecule, receptor, enzyme, or protein. Instead, it describes the broad biological phenomenon where monounsaturated fatty acids—primarily oleic acid found in olive oil—affect the function of various cells within the immune system. Animal studies indicate that diets rich in monounsaturated fats can alter lymphocyte composition and suppress certain aspects of immunity such as natural killer cell activity and lymphocyte proliferation. These effects are generally weaker than those observed with polyunsaturated fats like fish oils. In humans, evidence suggests that MUFA-rich diets do not cause general suppression of immunity but may subtly decrease some functions such as adhesion properties or trends toward reduced NK cell activity. Mechanistically, unsaturated fatty acids can be incorporated into cellular membranes affecting their fluidity and signaling capacity; they also serve as precursors for lipid mediators that regulate inflammation. The presence of free fatty acid receptors (such as FFA1/GPR40 and FFA4/GPR120) on macrophages and neutrophils further supports their role in modulating innate immunity by influencing cytokine release profiles—often promoting anti-inflammatory responses through M2 macrophage polarization when exposed to oleic acid. There is no recognized drug directly targeting this "modulation," nor is there an established biomarker specific for patient selection based on this mechanism. In summary: This entry does not represent an individual therapeutic target suitable for structured pharmacological databases—it is instead a description of how dietary components influence systemic immunology through multiple indirect mechanisms involving several molecular pathways rather than one discrete entity.
Not applicable as this is not a discrete molecular target but rather describes dietary/nutritional modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Modulation of immune response via monounsaturated fatty acids.